TSN222

· Tyligand Bioscience (Shanghai) Limited

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TSN222, covering 2024-07-29 to 2024-07-29. Get the full timeline:

Most recent: Clinical Trial Update: TSN222 in Subjects With Advanced Solid Tumors or Lymphomas [Phase 1, Phase 2]